These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
485 related articles for article (PubMed ID: 25552710)
1. Ebola virus and severe acute respiratory syndrome coronavirus display late cell entry kinetics: evidence that transport to NPC1+ endolysosomes is a rate-defining step. Mingo RM; Simmons JA; Shoemaker CJ; Nelson EA; Schornberg KL; D'Souza RS; Casanova JE; White JM J Virol; 2015 Mar; 89(5):2931-43. PubMed ID: 25552710 [TBL] [Abstract][Full Text] [Related]
2. Direct Visualization of Ebola Virus Fusion Triggering in the Endocytic Pathway. Spence JS; Krause TB; Mittler E; Jangra RK; Chandran K mBio; 2016 Feb; 7(1):e01857-15. PubMed ID: 26861015 [TBL] [Abstract][Full Text] [Related]
3. Direct Intracellular Visualization of Ebola Virus-Receptor Interaction by Mittler E; Alkutkar T; Jangra RK; Chandran K mBio; 2021 Jan; 12(1):. PubMed ID: 33436438 [TBL] [Abstract][Full Text] [Related]
4. Filoviruses Use the HOPS Complex and UVRAG To Traffic to Niemann-Pick C1 Compartments during Viral Entry. Bo Y; Qiu S; Mulloy RP; Côté M J Virol; 2020 Jul; 94(16):. PubMed ID: 32493822 [TBL] [Abstract][Full Text] [Related]
5. Multiple cationic amphiphiles induce a Niemann-Pick C phenotype and inhibit Ebola virus entry and infection. Shoemaker CJ; Schornberg KL; Delos SE; Scully C; Pajouhesh H; Olinger GG; Johansen LM; White JM PLoS One; 2013; 8(2):e56265. PubMed ID: 23441171 [TBL] [Abstract][Full Text] [Related]
6. Ebola virus triggers receptor tyrosine kinase-dependent signaling to promote the delivery of viral particles to entry-conducive intracellular compartments. Stewart CM; Phan A; Bo Y; LeBlond ND; Smith TKT; Laroche G; Giguère PM; Fullerton MD; Pelchat M; Kobasa D; Côté M PLoS Pathog; 2021 Jan; 17(1):e1009275. PubMed ID: 33513206 [TBL] [Abstract][Full Text] [Related]
7. Mapping of Ebolavirus Neutralization by Monoclonal Antibodies in the ZMapp Cocktail Using Cryo-Electron Tomography and Studies of Cellular Entry. Tran EE; Nelson EA; Bonagiri P; Simmons JA; Shoemaker CJ; Schmaljohn CS; Kobinger GP; Zeitlin L; Subramaniam S; White JM J Virol; 2016 Sep; 90(17):7618-27. PubMed ID: 27279622 [TBL] [Abstract][Full Text] [Related]
8. A novel Odongo L; Habtegebrael BH; Kiessling V; White JM; Tamm LK Microbiol Spectr; 2023 Sep; 11(5):e0190823. PubMed ID: 37728342 [TBL] [Abstract][Full Text] [Related]
10. Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection. Côté M; Misasi J; Ren T; Bruchez A; Lee K; Filone CM; Hensley L; Li Q; Ory D; Chandran K; Cunningham J Nature; 2011 Aug; 477(7364):344-8. PubMed ID: 21866101 [TBL] [Abstract][Full Text] [Related]
11. Potential pharmacological strategies targeting the Niemann-Pick C1 receptor and Ebola virus glycoprotein interaction. Morales-Tenorio M; Ginex T; Cuesta-Geijo MÁ; Campillo NE; Muñoz-Fontela C; Alonso C; Delgado R; Gil C Eur J Med Chem; 2021 Nov; 223():113654. PubMed ID: 34175537 [TBL] [Abstract][Full Text] [Related]
12. Ebolavirus Glycoprotein Directs Fusion through NPC1+ Endolysosomes. Simmons JA; D'Souza RS; Ruas M; Galione A; Casanova JE; White JM J Virol; 2016 Jan; 90(1):605-10. PubMed ID: 26468524 [TBL] [Abstract][Full Text] [Related]
13. Glycopeptide Antibiotics Potently Inhibit Cathepsin L in the Late Endosome/Lysosome and Block the Entry of Ebola Virus, Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV). Zhou N; Pan T; Zhang J; Li Q; Zhang X; Bai C; Huang F; Peng T; Zhang J; Liu C; Tao L; Zhang H J Biol Chem; 2016 Apr; 291(17):9218-32. PubMed ID: 26953343 [TBL] [Abstract][Full Text] [Related]
14. Sphingosine Kinases Promote Ebola Virus Infection and Can Be Targeted to Inhibit Filoviruses, Coronaviruses, and Arenaviruses Using Late Endocytic Trafficking to Enter Cells. Stewart CM; Bo Y; Fu K; Chan M; Kozak R; Apperley KY; Laroche G; Daniel R; Beauchemin AM; Kobinger G; Kobasa D; Côté M ACS Infect Dis; 2023 May; 9(5):1064-1077. PubMed ID: 37053583 [TBL] [Abstract][Full Text] [Related]
15. An exploration of conditions proposed to trigger the Ebola virus glycoprotein for fusion. Fénéant L; Szymańska-de Wijs KM; Nelson EA; White JM PLoS One; 2019; 14(7):e0219312. PubMed ID: 31276481 [TBL] [Abstract][Full Text] [Related]
16. A mutation in the Ebola virus envelope glycoprotein restricts viral entry in a host species- and cell-type-specific manner. Martinez O; Ndungo E; Tantral L; Miller EH; Leung LW; Chandran K; Basler CF J Virol; 2013 Mar; 87(6):3324-34. PubMed ID: 23302883 [TBL] [Abstract][Full Text] [Related]
17. Ligand-based design of peptide entry inhibitors targeting the endosomal receptor binding site of filoviruses. Wang LL; Estrada L; Wiggins J; Anantpadma M; Patten JJ; Davey RA; Xiang SH Antiviral Res; 2022 Oct; 206():105399. PubMed ID: 36007601 [TBL] [Abstract][Full Text] [Related]
18. Novel Small Molecule Entry Inhibitors of Ebola Virus. Basu A; Mills DM; Mitchell D; Ndungo E; Williams JD; Herbert AS; Dye JM; Moir DT; Chandran K; Patterson JL; Rong L; Bowlin TL J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S425-34. PubMed ID: 26206510 [TBL] [Abstract][Full Text] [Related]
19. The phosphatidylinositol-3-phosphate 5-kinase inhibitor apilimod blocks filoviral entry and infection. Nelson EA; Dyall J; Hoenen T; Barnes AB; Zhou H; Liang JY; Michelotti J; Dewey WH; DeWald LE; Bennett RS; Morris PJ; Guha R; Klumpp-Thomas C; McKnight C; Chen YC; Xu X; Wang A; Hughes E; Martin S; Thomas C; Jahrling PB; Hensley LE; Olinger GG; White JM PLoS Negl Trop Dis; 2017 Apr; 11(4):e0005540. PubMed ID: 28403145 [TBL] [Abstract][Full Text] [Related]
20. Ebola virus requires phosphatidylinositol (3,5) bisphosphate production for efficient viral entry. Qiu S; Leung A; Bo Y; Kozak RA; Anand SP; Warkentin C; Salambanga FDR; Cui J; Kobinger G; Kobasa D; Côté M Virology; 2018 Jan; 513():17-28. PubMed ID: 29031163 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]